Trade Mark Journal No.2026/009 27 February 2026
WO0000001901853 (5)
Office of origin: United States of America
Date of International Registration:16 January 2026
Date of designation in the UK:
16 January 2026

- Class 5
- Pharmaceutical preparations and substances for the treatment of immunological and neurological diseases and disorders.
UCB BIOSCIENCES, INC.
Representative: Kumiko Ide Wenderoth, Lind & Ponack, LLP, 1025 Connecticut Avenue NW, Suite 500, Washington DC 20036, UNITED STATES OF AMERICA